Closed
7.84 -0.25
24h
Min
7.84
Max
7.88
Income | -13M |
---|---|
Sales | 340K 340K |
EPS | -0.15 |
Profit margin | -3,762.059 |
Employees | 34 |
EBITDA | -13M |
Recommendations | Neutral |
---|---|
12 Months Forecast | +11.82% upside |
Next Earnings | 14 maj 2025 |
---|
Market Cap | 310M 545M |
---|---|
Previous open | 8.09 |
Previous close | 7.84 |
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 8.8 USD 11.82%
High 11 USD
Low 7 USD
Based on 6 Wall Street analysts offering 12 month price targets forRegulus Therapeutics Inc - Dist in the last 3 months.
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$